Keyphrases
Dose Escalation
100%
Single Institution
100%
Nonoperative
100%
Locally Advanced Esophageal Carcinoma
100%
Chemoradiation
66%
5-fluorouracil (5-FU)
66%
Histology
33%
Progression-free Survival
33%
Overall Survival
33%
Phase I Study
33%
Poor Outcome
33%
2-cycles
33%
Radiation Therapy
33%
Adenocarcinoma
33%
Concurrent Cisplatin
33%
Concurrent Chemotherapy
33%
At-risk
33%
Tolerability
33%
Esophageal Carcinoma
33%
Distant Recurrence
33%
Locoregional
33%
Radiation Dose Escalation
33%
Distant Failure
33%
Cardiac Events
33%
Cisplatin
33%
Historical Controls
33%
Advanced Esophageal Cancer
33%
Distal Esophagus
33%
Overall Survival Progression-free Survival
33%
7th Edition
33%
Simultaneous Integrated Boost
33%
Definitive Management
33%
Medicine and Dentistry
Intensity Modulated Radiation Therapy
100%
Esophagus Carcinoma
100%
Progression Free Survival
66%
Overall Survival
66%
Cisplatin
66%
Chemoradiotherapy
66%
Prospective Study
33%
Esophagus
33%
Esophageal Cancer
33%
Adenocarcinoma
33%
Recurrent Disease
33%
Radiation Dose Escalation
33%
Diseases
33%
Radiation Therapy
33%
Pharmacology, Toxicology and Pharmaceutical Science
Esophagus Carcinoma
100%
Progression Free Survival
66%
Overall Survival
66%
Chemoradiation Therapy
66%
Cisplatin
66%
Prospective Study
33%
Chemotherapy
33%
Esophagus Cancer
33%
Adenocarcinoma
33%
Recurrent Disease
33%
Tolerability
33%
Diseases
33%